Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Oregon
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Oregon
3 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Oregon.
Cities in Oregon
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1614, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07032662A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Portland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic - Marquam Hill, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.